117 related articles for article (PubMed ID: 24476897)
1. Why routine clinical follow-up for patients with early stage endometrial cancer is not always necessary: a study on women in South Wales.
Aung L; Howells RE; Lim KC; Hudson E; Jones PW
Int J Gynecol Cancer; 2014 Mar; 24(3):556-63. PubMed ID: 24476897
[TBL] [Abstract][Full Text] [Related]
2. Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis.
Carrara L; Gadducci A; Landoni F; Maggino T; Scambia G; Galletto L; Lissoni AA; Fuso L; Zola P; Sartori E
Int J Gynecol Cancer; 2012 Jul; 22(6):1013-9. PubMed ID: 22706226
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma.
Xu Y; Burmeister C; Hanna RK; Munkarah A; Elshaikh MA
Int J Gynecol Cancer; 2016 Jul; 26(6):1137-42. PubMed ID: 27206283
[TBL] [Abstract][Full Text] [Related]
4. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.
Kiran G; Kesterson JP; Ozerkan K; Kanis M; Groman A; Lele S
Eur J Gynaecol Oncol; 2013; 34(6):522-6. PubMed ID: 24601043
[TBL] [Abstract][Full Text] [Related]
6. Costs and benefits of routine follow-up after curative treatment for endometrial cancer.
Agboola OO; Grunfeld E; Coyle D; Perry GA
CMAJ; 1997 Oct; 157(7):879-86. PubMed ID: 9327795
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of endometrial carcinoma and the value of routine follow up.
Salvesen HB; Akslen LA; Iversen T; Iversen OE
Br J Obstet Gynaecol; 1997 Nov; 104(11):1302-7. PubMed ID: 9386033
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme.
Reddoch JM; Burke TW; Morris M; Tornos C; Levenback C; Gershenson DM
Gynecol Oncol; 1995 Nov; 59(2):221-5. PubMed ID: 7590477
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the treatment-free interval in patients with recurrent endometrial cancer.
Shimamoto K; Saito T; Okadome M; Shimokawa M
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():92-6. PubMed ID: 24472691
[TBL] [Abstract][Full Text] [Related]
10. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract][Full Text] [Related]
11. Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.
Jeppesen MM; Mogensen O; Hansen DG; Iachina M; Korsholm M; Jensen PT
Acta Oncol; 2017 Feb; 56(2):262-269. PubMed ID: 28080157
[TBL] [Abstract][Full Text] [Related]
12. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
13. Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer.
Jeppesen MM; Jensen PT; Hansen DG; Christensen RD; Mogensen O
BJOG; 2018 Dec; 125(13):1705-1714. PubMed ID: 29978593
[TBL] [Abstract][Full Text] [Related]
14. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of endometrial cancer patients with and without symptoms at recurrence.
Yoshiba T; Takei Y; Machida S; Taneichi A; Sato N; Takahashi S; Takahashi Y; Saga Y; Matsubara S; Fujiwara H
J Obstet Gynaecol Res; 2016 Dec; 42(12):1814-1821. PubMed ID: 27526662
[TBL] [Abstract][Full Text] [Related]
16. Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study.
Gadducci A; Fuso L; Cosio S; Landoni F; Maggino T; Perotto S; Sartori E; Testa A; Galletto L; Zola P
Int J Gynecol Cancer; 2009 Apr; 19(3):367-74. PubMed ID: 19407561
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
20. The outcome of patients with stage I endometrial cancer involving the lower uterine segment.
Lavie O; Uriev L; Gdalevich M; Barak F; Peer G; Auslender R; Anteby E; Gemer O
Int J Gynecol Cancer; 2008; 18(5):1079-83. PubMed ID: 18081795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
